Wild-type and attenuated influenza virus infection of the neonatal rat brain
Although influenza virus infection of humans has been associated with a wide spectrum of clinical neurological syndromes, the pathogenesis of influenza virus associated central nervous system (CNS) disease in humans remains controversial. To better study influenza virus neuropathogenesis, an animal model of influenza-associated CNS disease using human virus isolates without adaptation to an animal host was developed. This neonatal rat model of influenza virus CNS infection was developed using low-passage human isolates and shows outcomes in specific brain regions, cell types infected, and neuropathological outcomes that parallel the available literature on cases of human CNS infection. The degree of virus replication and spread in the rat brain correlated with the strains’ neurotoxicity potential for humans. In addition, using sensitive neurobehavioral test paradigms, changes in brain function were found to be associated with areas of virus replication in neurons. These data suggest that further evaluation of this pathogenesis model may provide important information regarding influenza virus neuropathogenesis, and that this model may have possible utility as a preclinical assay for evaluating the neurological safety of new live attenuated influenza virus vaccine strains.
Keywordsinfluenza virus neurotropism neurovirulence rat vaccine
Unable to display preview. Download preview PDF.
- Dowdle WR, Schild GC (1975). Laboratory propagation of human influenza viruses, experimental host range, and isolation from clinical material. In The influenza viruses and influenza. Kilbourne E (ed). New York: Academic Press, pp 243–268.Google Scholar
- Edelen J, Bender T, Chin T (1974). Encephalopathy and pericarditis during an outbreak of influenza. Am J Epidemol 100: 79–84.Google Scholar
- European Pharmacopeia Comission (1997). Tests for neurovirulence of live virus vaccines (general method no. 2.6.18). In European pharmacopeia, p 99.Google Scholar
- Mori S, Nagashima M, Sasaki Y, Mori K, Tabei Y, Yoshida Y, Yamazaki K, Hirata I, Ito T, Suzuki S (1999). A novel amino acid substitution at the receptor-binding site on the hemagglutinin of H3N2 influenza A viruses isolated from 6 cases with acute encephalopathy during the 1997–1998 season in Tokyo. Arch Virol 144: 147–155.CrossRefPubMedGoogle Scholar
- Nakai Y, Itoh M, Mizuguchi M, Ozawa H, Okazaki E, Kobayashi Y, Takahashi M, Ohtani K, Ogawa A, Narita M, Togashi T, Takashima S (2003). Apoptosis and microglial activation in influenza encephalopathy. Acta Neuropathol (Berl) 105: 233–239.Google Scholar
- Rose E, Prabhakar P (1982). Influenza A virus associated neurological disorders in Jamaica. WI Med J 31: 29–33.Google Scholar
- The European Agency for the Evaluation of Medicinal Products (2003). Points to consider on the development of live attenuated influenza vaccines. EMEA/CPMP/ BWP/2289/01.Google Scholar